[go: up one dir, main page]

AR026913A1 - Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales - Google Patents

Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales

Info

Publication number
AR026913A1
AR026913A1 ARP000106509A ARP000106509A AR026913A1 AR 026913 A1 AR026913 A1 AR 026913A1 AR P000106509 A ARP000106509 A AR P000106509A AR P000106509 A ARP000106509 A AR P000106509A AR 026913 A1 AR026913 A1 AR 026913A1
Authority
AR
Argentina
Prior art keywords
purin
analogs
cis
methanol
amino
Prior art date
Application number
ARP000106509A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR026913A1 publication Critical patent/AR026913A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se refiere a análogos de (1S,cis)-4-(2-amino-9H-purin-9-il)-2-ciclopenteno-1-metanol para usarse en el tratamiento de infeccionesvirales.
ARP000106509A 1999-12-10 2000-12-07 Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales AR026913A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17022599P 1999-12-10 1999-12-10

Publications (1)

Publication Number Publication Date
AR026913A1 true AR026913A1 (es) 2003-03-05

Family

ID=22619059

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106509A AR026913A1 (es) 1999-12-10 2000-12-07 Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales

Country Status (9)

Country Link
EP (1) EP1235833B1 (es)
JP (1) JP2003516409A (es)
AR (1) AR026913A1 (es)
AT (1) ATE260288T1 (es)
AU (1) AU2068901A (es)
DE (1) DE60008580T2 (es)
ES (1) ES2213061T3 (es)
PE (1) PE20010915A1 (es)
WO (1) WO2001042256A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201513601D0 (en) * 2015-07-31 2015-09-16 Univ Liverpool Antiviral compounds
JP7104154B2 (ja) * 2018-07-27 2022-07-20 富士フイルム株式会社 シクロペンテニルプリン誘導体またはその塩
JP7041748B2 (ja) 2018-07-27 2022-03-24 富士フイルム株式会社 シクロブチルプリン誘導体またはその塩
WO2024107859A1 (en) * 2022-11-15 2024-05-23 Rome Therapeutics, Inc. Cyclopentene-oxymethylene phosphonamidates and related compounds and their use in treating medical conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
JP2002536452A (ja) * 1999-02-12 2002-10-29 グラクソ グループ リミテッド 抗ウイルス剤としての（１Ｒ，ｃｉｓ）−４−（６−アミノ−９Ｈ−プリン−９−イル）−２−シクロペンテン−１−メタノールのホスホルアミダート、ならびに一、二および三リン酸エステル

Also Published As

Publication number Publication date
DE60008580T2 (de) 2004-08-05
EP1235833A1 (en) 2002-09-04
PE20010915A1 (es) 2001-09-29
ATE260288T1 (de) 2004-03-15
AU2068901A (en) 2001-06-18
EP1235833B1 (en) 2004-02-25
DE60008580D1 (en) 2004-04-01
ES2213061T3 (es) 2004-08-16
WO2001042256A1 (en) 2001-06-14
JP2003516409A (ja) 2003-05-13

Similar Documents

Publication Publication Date Title
ECSP045069A (es) Uso de flibanserina en el tratamiento de trastornos sexuales
HN2001000190A (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
HN1999000015A (es) Tratamiento para una disfuncion sexual femenina
GEP20094767B (en) C-class oligonucleotide analogs with enhanced immunostimulatory potency
PT1265889E (pt) Medicamentos contra patologias virais
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
UY26495A1 (es) " derivados de tiazolilamida"
TW200505875A (en) Novel compounds
AR021643A1 (es) Combinacion de cerivastatina y fibratos.
MY129372A (en) Process to prepare oxazolidinones
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
SE9901077D0 (sv) Novel use
HN1998000099A (es) Formas de dosificacion de sertralina de liberacion retardada
CR9108A (es) Prevencion de infecciones endoparasitas verticales
AR026913A1 (es) Analogos de (1s-cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales
PE20011080A1 (es) Uso de mirtazapina para el tratamiento de trastornos del sueno
PT1357932E (pt) Modificacao cristalina de um depsipeptido ciclico com eficacia melhorada
DK1729732T3 (da) Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
BR0006843A (pt) Dispositivo de embreagem
BR0010499A (pt) Agentes endoparasiticidas
DK1401492T3 (da) LTB4 som vaccineadjuvans
DE602004022578D1 (de) Antitumorale terpen-verbindungen
DE50003634D1 (de) SPRAY, ENTHALTEND UBICHINON Qn

Legal Events

Date Code Title Description
FB Suspension of granting procedure